LifeMD Financials - Benzinga

LifeMD Inc

LFMDNASDAQ

Trade with Public

Trade with Public

$3.28

-0.12-3.53%

At close: Aug 20, 5:00 PM EST

$3.28

0.00010%

After Hours: 6:25 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

LifeMD Financials

LifeMD (LFMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est

LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500 million-$212.500 million vs $222.046 million estimate.

Benzinga Newsdesk

PRO
LifeMD Sees Q3 Sales $48.000M-$51.000M vs $58.547M Est

LifeMD (NASDAQ:LFMD) sees Q3 sales of $48.000 million-$51.000 million vs $58.547 million analyst estimate.

Benzinga Newsdesk

PRO
LifeMD Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $47.300M Miss $49.152M Estimate

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 166.67 percent decrease over losses of $(0.06) per share from the

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
LifeMD Affirms FY2026 Sales Guidance of $220.000M-$230.000M vs $223.588M Est

LifeMD (NASDAQ:LFMD) affirms FY2026 sales outlook from $220.000 million-$230.000 million to $220.000 million-$230.000 million vs $223.588 million estimate.

Benzinga Newsdesk

PRO
LifeMD Sees Q2 Sales $47.000M-$50.000M vs $53.989M Est

LifeMD (NASDAQ:LFMD) sees Q2 sales of $47.000 million-$50.000 million vs $53.989 million analyst estimate.

Benzinga Newsdesk